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METHODS
Cell Culture
The following cell lines were maintained at 37°C with 7% CO 2 in humidified incubators. All tissue culture reagents were purchased from Thermo Fisher Scientific (Waltham, MA) unless stated otherwise. HeLa-JVM cells (1) were grown in high-glucose DMEM supplemented with 10% Fetal Bovine Serum (FBS), 100 U/mL penicillin-streptomycin, and 0.29 mg/mL L-glutamine.
HeLa-HA cells (2) were grown in MEM supplemented with 10% FBS, 100 U/mL penicillinstreptomycin, 0.29 mg/mL L-glutamine, and 0.1 mM nonessential amino acids. PA-1 cells (3) were grown in MEM supplemented with 10% FBS, 100 U/mL penicillin-streptomycin, 0.29 mg/mL L-glutamine, and 0.1 mM nonessential amino acids. H9 human embryonic stem cells (hESCs) and H9-hESC-derived neural progenitor cells were cultured and maintained by the Garcia-Perez lab as described previously (4) (5) (6) .
Plasmids
All human L1 expression plasmids contain the L1.3 (GenBank accession no. L19088) (7) DNA cloned into the pCEP4 mammalian expression vector (Thermo Fisher Scientific) unless stated otherwise. A CMV promoter augments the expression of L1 in these plasmids unless noted otherwise. The L1 expression plasmids contain a SV40 polyadenylation signal that is located downstream of the native L1 polyadenylation signal. All plasmid DNA was prepared with a Midiprep Plasmid DNA Kit (Qiagen, Germany). pJM101/L1.3Δneo: is an engineered plasmid expression vector that expresses an active wildtype human L1 element (L1.3) (8) . The L1 element has been cloned into a pCEP4 expression vector (Thermo Fisher Scientific). L1 expression is augmented by a CMV promoter located at the 5' end of the L1 and an SV40 polyadenylation sequence that flanks the 3' end of the L1. pJM108/L1.3Δneo: is similar to pJM101/L1.3Δneo, but contains a S119X stop mutation in ORF1p (1, 8, 9) pJM105/L1.3Δneo: is similar to pJM101/L1.3Δneo, but contains a D702A missense mutation in the ORF2p RT active site (8) .
pJBM119/L1.3Δneo: is similar to pJM101/L1.3Δneo, but also contains a H230A mutation in the ORF2p EN domain and a D702A missense mutation in the ORF2p RT active site.
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each round of nested PCR. PCR products (10-20 µL) were visualized on 2% agarose gels using SYBR safe DNA gel stain (Thermo Fisher Scientific).
Cloning and Sequencing of RT-PCR products
Visible cDNA bands were excised from agarose gels and the cDNA was purified using the Wizard SV Gel and PCR Clean-Up System (Promega). For transfected HeLa cell RT-PCR experiments (Fig. 1C) , RT-PCR products from untransfected HeLa cells could not be analyzed due to a lack of visible cDNA bands. Purified DNA from excised gel slices was cloned into a pCR4-TOPO TA vector (Thermo Fisher Scientific), DNA was isolated from individual clones using a Wizard Plus SV miniprep DNA purification kit (Promega) and subjected to Sanger DNA sequencing at the University of Michigan DNA sequencing core facility.
For in vitro reactions (Figs. 2, 3, and S3G), equivalent sized gel slices that corresponded to the expected RT-PCR product size (~305 and ~232 base pairs for U6/L1 and U6/GFP, respectively) were excised from each lane regardless of whether a band was visible under UV illumination, cloned, and sequenced as described above.
Generation of synthetic U6, L1, and GFP RNA
To generate the synthetic U6 snRNA bearing a 2',3'-cyclic phosphate (U6>P), a doublestranded DNA template (gBlock Gene Fragments, IDT technologies, Coralville, IA) was designed that consisted of a T7 promoter joined to the human U6 snRNA sequence ending in 4 thymidines followed by the sequence of a mutant form of the hepatitis delta virus (HDV) antigenomic ribozyme sequence (T7-U6-HDVr) (10, 11) (SI Appendix, Fig. S2A and Tables S2   and S9) . A control template lacking the HDV ribozyme sequence (T7-U6) was used to generate synthetic U6 snRNA bearing a 3'-OH (U6-OH) (SI Appendix, Table S9 ).
To generate a synthetic L1 RNA fragment with a 5'-OH (OH-L1), a double-stranded DNA template (gBlock Gene Fragments, IDT technologies) was designed that consisted of a T7 promoter followed by an engineered hammerhead ribozyme (HHr) sequence and pJM101/L1.3Δneo nucleotides 5752-6087 (T7-HHr-L1) (12) (SI Appendix, Table S9 ). A control L1 template was also made that lacked the HHr sequence (T7-L1) in order to generate an L1 RNA fragment bearing a 5'-triphosphate (P-L1) (SI Appendix, Table S9 ).
To generate a synthetic GFP RNA fragment with a 5'-OH (OH-GFP), a double-stranded DNA template (gBlock Gene Fragments, IDT technologies) was designed that consisted of a T7 promoter followed by an engineered hammerhead ribozyme sequence and pCEP-GFP (9) nucleotides 471-780 (T7-HHr-GFP) (12) (SI Appendix, Table S9 ). The GFP RNA sequence consists of nucleotides 471-720 of the hrGFP ORF sequence followed by 60 nucleotides of the SV40 polyadenylation sequence from the pCEP4 vector (SI Appendix, Table S9 ).
To generate synthetic RNAs, double-stranded DNA gBlock templates were first PCR amplified using Platinum Taq DNA Polymerase (Thermo Fisher Scientific). PCR-amplified templates were then purified from agarose gels using the Wizard SV Gel and PCR Clean-Up System (Promega). For in vitro transcription reactions, approximately 100-300 ng of template DNA was used in 40 µL reactions using a MAXIscript T7 transcription kit (Thermo Fisher Scientific). Reactions were incubated at 37°C for 2.5 hours and then treated with 4 µL of DNase I (Thermo Fisher Scientific) and concentrated using an RNA Clean & Concentrator kit (Zymo Research, Irvine, CA). RNA was eluted from columns with water and diluted to a final concentration of ~50-100 ng/µL and stored at -80°C.
Two microliters (~100-200 ng) of RNA from T7 transcription reactions was analyzed using denaturing Urea-PAGE. Gels were stained with SYBR Green II RNA gel stain (Thermo Fisher Scientific) to visualize the RNA.
U6/L1 RNA ligation reactions using purified RtcB
In vitro transcribed U6 and L1 RNAs were first splinted with a DNA oligonucleotide (SI Appendix, Table S9 ) by combining U6 and L1 RNA with the DNA oligonucleotide splint (~500 nM final concentration for each RNA and DNA oligo diluted in water; 10 µL final reaction volume). The RNA/DNA oligo mixture was then incubated at 65°C for 5 minutes, 25°C for 3 minutes, and then kept at 4°C for approximately 10 minutes before being added to the ligation reaction. Next, U6/L1 ligation reactions (4 µL final volume) containing 50 mM Tris-HCl (pH 8.0), 2 mM MnCl 2 , 100 µM GTP, 2 µM purified RtcB from E. coli (13) , and splinted U6 and L1 RNA substrates (~250 nM final concentration for each RNA and DNA oligo) were incubated at 37°C for 1 hour. The reactions were concentrated using an RNA Clean & Concentrator kit (Zymo Research), which included an on-column DNase I (Thermo Fisher Scientific) digestion. RNA was eluted with two volumes (8 µL each) of water.
Following ligation reactions, cDNAs were prepared using 3 µL of concentrated RNA with the SuperScript First-Strand Synthesis System for RT-PCR (Thermo Fisher Scientific) using the SV40as oligonucleotide primer. Reverse transcription (RT) reactions were incubated at 42°C for 50 minutes followed by an incubation at 70°C for 15 minutes. RT reactions (20 µL) were then diluted 1:1 with water to a final volume of 40 µL.
Following the RT step, nested PCR was then carried out using Platinum Taq DNA Polymerase (Thermo Fisher Scientific) according to the manufacturer's protocol in 50 µL reactions using 2 µL of template cDNA from the above RT reactions, 0.25 µL Platinum Taq, 0.2 µM forward and reverse primers, 1.5 mM MgCl 2 and 0.2 mM dNTPs. The first round of PCR used the following primers: U6s1 (sense) and SV40as (antisense). The second round of PCR used: U6s2 (sense) and 3UTRas (antisense). Thermal cycler conditions were as follows: initial cycle of 94°C for 2 minutes, followed by 30 cycles of 30 seconds at 94°C, 30 seconds at 55°C, and 60 seconds at 72°C with a final cycle of 72°C for 5 minutes. PCR conditions were identical for each round of nested PCR. PCR products (10-20 µL) were visualized on 2% agarose gels using SYBR safe DNA gel stain (Thermo Fisher Scientific). For all reactions, gel slices were excised from each lane and processed for Sanger sequencing as described above.
U6/L1 RNA ligation reactions using HeLa cell extracts
HeLa cell nuclear extracts were either prepared from HeLa-JVM cells (14, 15) or purchased from Protein One (Rockville, MD, P0002-02). The nuclear extracts generated in the lab and the commercially sourced HeLa nuclear extracts both performed similarly in ligation reactions. Following the RT step, PCR was then carried out using Platinum Taq DNA Polymerase (Thermo Fisher Scientific) according to the manufacturer protocol in 50 µL reactions using 2 µL of template cDNA from the above RT reactions, 0.25 µL Platinum Taq, 0.2 µM forward and reverse primers, 1.5 mM MgCl 2 and 0.2 mM dNTPs. The first round of PCR used the following primers: U6s1 (sense) and SV40as (antisense). The second round of PCR used: U6s2 (sense) and 3UTRas (antisense). Thermal cycler conditions were as follows: initial cycle of 94°C for 2 minutes, followed by 30 cycles of 30 seconds at 94°C, 30 seconds at 55°C, and 60 seconds at 72°C with a final cycle of 72°C for 5 minutes. PCR conditions were identical for each round of nested PCR. PCR products (10-20 µL) were visualized on 2% agarose gels using SYBR safe DNA gel stain (Thermo Fisher Scientific). For all reactions, gel slices were excised from each lane and processed for Sanger sequencing as described above.
CRISPR/Cas9 depletion of RtcB from HeLa cells
To deplete RtcB protein expression in HeLa-JVM cells, a single guide RNA targeting exon 2 of human RtcB (SI Appendix, Table S9 ) (16) was cloned into the BbsI site of the pX459v2 plasmid vector (17) . As a control, an sgRNA targeting GFP (SI Appendix, Real-Time PCR system (Thermo Fisher Scientific) using following thermal cycling conditions:
initial cycle of 50°C for 2 minutes; 95°C for 2 minutes; followed by 40 cycles of 15 seconds at 95°C, 28 seconds at 54°C, and 60 seconds at 72°C.
The relative standard curve method was used to quantify U6/L1 ligation efficiency. Standard curves for each primer pair were generated using serial 10-fold dilutions of a 402 bp U6/L1 double stranded DNA template (U6L1_qPCR_standard) consisting of U6 snRNA nucleotides (41-106) conjoined to pJM101/L1.3Δneo nucleotides 5752-6087 (SI Appendix, Table S9; concentration range: 1x10 -12 M -1x10 -16 M). U6/L1 ligation efficiency was determined by the ratio of U6/L1 junction molecules over L1 endogenous control molecules. For each experiment, untransfected HeLa-JVM nuclear extracts were used as a calibrator and each sgRNA condition were considered different treatments. Thus, U6/L1 ligation efficiency was normalized to untransfected HeLa-JVM cell extracts. The normalized ligation efficiency for each reaction condition was calculated by averaging the values from 6 independent RT-qPCR experiments. A two-tailed Student's t-test was used to determine p values.
Western Blotting
Standard western blotting procedures were used for protein analysis. Blots were analyzed using an Odyssey CLx (LI-COR, Lincoln, NE). Western blot quantification was performed using 
U6/GFP RNA ligation reactions using HeLa cell extracts
HeLa cell nuclear extracts were prepared as described above. U6/L1 ligation reactions (final 
RNA-sequencing (RNA-seq)
All cDNA library preparation and sequencing was conducted at the University of Michigan sequencing core facility (Ann Arbor, MI). Briefly, total RNA was collected from HeLa-JVM, HeLa-HA, and PA-1 cells using an RNeasy mini kit (Qiagen) according to the manufacturer's instructions. Total RNA from hESC (4, 5) , and hESC derived NPCs (6) was a generous gift of Dr. Jose Garcia-Perez. To generate cDNA libraries, total RNA from each cell line was first depleted of ribosomal RNA using a Ribo-Zero rRNA removal kit (Illumina, San Diego, CA), and then cDNA libraries were generated from the rRNA-depleted RNA using the TruSeq Stranded mRNA Library Prep Kit (Illumina) with random hexamers according to manufacturer protocol with the following deviations: RNA was fragmented for 1 minute to generate ~190 nucleotide fragments and 12 PCR cycles were used to enrich DNA fragments after ligating adapters.
Paired-end sequencing (100 bp reads) was performed on the Illumina HiSeq 2500. RNA-seq data for PA-1, H9, and NPCs has previously been deposited to the Sequence Read Archive (SRA: PRJNA432733) (18) . HeLa RNA-seq data has previously been deposited to dbGaP (dbGaP: phs00167) (18) .
RNA Sequencing Analysis
Trimmomatic (19) was used to trim the sequencing adaptors from a total of ~1.1 X 10 9 RNA sequencing reads. We assessed the quality of our data using FastQC (Andrews S. [2010] .
FastQC: a quality control tool for high throughput sequence data. hg38 with all repeats masked using RepeatMasker and RepBase (21), but including a single representative copy of a human specific L1 (L1.3; GenBank accession no. L19088) (7) and human U6 snRNA (GenBank accession no. X59362). FLASH (22) then was used to reconstruct overlapping read pairs that aligned at one end to the 3' portion of U6 snRNA and the other end to L1. Merged U6/L1 sequences that contained U6 snRNA sequence at the 5' end conjoined to L1 sequence at the 3' end were then mapped back to the non-masked HGR (HGR/build Grch38) using BWA-MEM in order to differentiate events aligned to the genome from those which did not exhibit a clear mapping (Fig. 4) . Our software for extracting these fusion reads from RNA-seq data can be found at https://github.com/mills-lab/U6L1. All U6/L1 reads were manually aligned to the HGR using BLAT (23) to verify BWA-MEM alignments. The L1 portion of each U6/L1 read was manually aligned to the L1.3 sequence and consensus sequences from L1 subfamilies (L1PA1-L1PA13) (24) to determine the L1 subfamily and to derive L1 sequences for L1 junction analyses (Figs. S4A and S4B; Tables S4 and S5 ).
U6/L1 Junction Motif Search of HeLa cells and 1000 Genomes Project High Coverage Samples
Motifs across putative U6/L1 junctions were extracted from all merged reads as described above. Each 25 base pair junction motif contains U6 snRNA nucleotides 94-102 followed by 5-8 thymidines and ~8-11 nucleotides of L1 sequence (SI Appendix, Table S6 ). All motifs and their reverse complements were used to interrogate HeLa cell genomic data from dbGaP (dbGaP accession number phs000640.v1.p1) (25) (26) (27) and 23 high coverage PCR-free DNA sequencing samples from the 1000 Genomes Project (SI Appendix, Table S9 ) (28) to look for genomic evidence of each U6/L1 junction sequence. The script for 25 base pair motif search is available at: https://github.com/mills-lab/U6L1. An exact match was required for labeling the existence of the junction from the HeLa genomic and 1000 Genomes DNA sequencing data. Two exceptions were noted in the 1000 genomes data, in which two genomes (NA20845 and HG03742) contained the same SNP within the U6 sequence for the U6/L1 chimera sequence with L1.3 junction 2052 and therefore did not initially exhibit an exact match to the genomic sequences of these samples (see Results and SI Appendix, Table S6 ).
HeLa cell genome sequence data
The HeLa cell genome sequence data used for analysis described in this manuscript were obtained from the database of Genotypes and Phenotypes (https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000640.v5.p1). This study was reviewed by the NIH HeLa Genome Data Access Working Group. (green rectangle) containing a 5'-OH (black circle) were generated using a ribozyme-based in vitro transcription reaction. The resultant RNAs were incubated with HeLa cell nuclear extracts as described in Fig. 4A and cDNAs were synthesized using the SV40as oligonucleotide primer.
RT-PCR reactions using nested primers (U6s1 and GFPas1, then U6s2 and GFPas2) were used to detect U6/GFP chimeric cDNAs. Table S5 . For weblogo analyses, 5Ts were assigned to U6 and the remaining T's at the U6/L1 junction were assigned to L1. Table S1 . 
TABLE LEGENDS
Predicted change to RtcB amino acid sequence: 
R51S, ΔN52-G58
HeLa clone Table S5 . Analysis of "non-aligned" U6/L1 sequences from RNA-seq experiments * ** * Table S9 . Oligos used in this study. 
